Clinical Trials
3 trialsNCT07110584 2026-03-05
Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
ModeX Therapeutics, An OPKO Health Company
Phase 1/2 Recruiting
NCT05867771 2023-05-22
A Study of PM1022 in Patients With Advanced Tumors
Biotheus Inc.
Phase 1/2 Unknown
NCT02419417 2022-06-16
BET
Bristol-Myers Squibb
Phase 1/2 Completed